Loading...

Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer

BACKGROUND: Little evidence has been generated for how best to manage patients with non-small-cell lung cancer (nsclc) presenting with rarer clinical scenarios, including oligometastases, oligoprogression, and pseudoprogression. In each of those scenarios, oncologists have to consider how best to ba...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Oncol
Main Authors: Laurie, S.A., Banerji, S., Blais, N., Brule, S., Cheema, P.K., Cheung, P., Daaboul, N., Hao, D., Hirsh, V., Juergens, R., Laskin, J., Leighl, N., MacRae, R., Nicholas, G., Roberge, D., Rothenstein, J., Stewart, D.J., Tsao, M.S.
Format: Artigo
Sprog:Inglês
Udgivet: Multimed Inc. 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380642/
https://ncbi.nlm.nih.gov/pubmed/30853813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4116
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!